Progyny (PGNY) Competitors $15.15 +0.15 (+1.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PGNY vs. TVTY, ARA, SHC, CO, VMD, MGRX, MRAI, BRTX, OTRK, and NIVFShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Tivity Health (TVTY), American Renal Associates (ARA), Sotera Health (SHC), Global Cord Blood (CO), Viemed Healthcare (VMD), Mangoceuticals (MGRX), Marpai (MRAI), BioRestorative Therapies (BRTX), Ontrak (OTRK), and NewGenIvf Group (NIVF). Progyny vs. Tivity Health American Renal Associates Sotera Health Global Cord Blood Viemed Healthcare Mangoceuticals Marpai BioRestorative Therapies Ontrak NewGenIvf Group Tivity Health (NASDAQ:TVTY) and Progyny (NASDAQ:PGNY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, community ranking, dividends, risk and profitability. Do institutionals & insiders hold more shares of TVTY or PGNY? 91.5% of Tivity Health shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 2.0% of Tivity Health shares are held by company insiders. Comparatively, 12.3% of Progyny shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, TVTY or PGNY? Tivity Health has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Which has stronger valuation and earnings, TVTY or PGNY? Tivity Health has higher earnings, but lower revenue than Progyny. Tivity Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTivity Health$481.25M3.37$104.91M$1.7119.01Progyny$1.09B1.26$62.04M$0.6324.05 Is TVTY or PGNY more profitable? Tivity Health has a net margin of 17.25% compared to Progyny's net margin of 5.54%. Tivity Health's return on equity of 75.94% beat Progyny's return on equity.Company Net Margins Return on Equity Return on Assets Tivity Health17.25% 75.94% 13.65% Progyny 5.54%11.97%8.43% Does the MarketBeat Community favor TVTY or PGNY? Tivity Health received 311 more outperform votes than Progyny when rated by MarketBeat users. However, 72.59% of users gave Progyny an outperform vote while only 53.12% of users gave Tivity Health an outperform vote. CompanyUnderperformOutperformTivity HealthOutperform Votes40953.12% Underperform Votes36146.88% ProgynyOutperform Votes9872.59% Underperform Votes3727.41% Does the media prefer TVTY or PGNY? In the previous week, Progyny had 4 more articles in the media than Tivity Health. MarketBeat recorded 4 mentions for Progyny and 0 mentions for Tivity Health. Progyny's average media sentiment score of 0.25 beat Tivity Health's score of 0.00 indicating that Progyny is being referred to more favorably in the news media. Company Overall Sentiment Tivity Health Neutral Progyny Neutral Do analysts prefer TVTY or PGNY? Progyny has a consensus target price of $27.73, indicating a potential upside of 83.02%. Given Progyny's higher probable upside, analysts plainly believe Progyny is more favorable than Tivity Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tivity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AProgyny 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 SummaryProgyny beats Tivity Health on 9 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.37B$1.96B$5.02B$8.40BDividend YieldN/A2.27%7.52%4.16%P/E Ratio24.0520.56129.2216.66Price / Sales1.265.931,719.4176.49Price / Cash22.4210.9136.9133.53Price / Book2.634.264.605.02Net Income$62.04M$69.56M$114.45M$223.81M7 Day Performance-4.30%-2.85%0.37%2.28%1 Month Performance-7.06%-3.88%10.41%8.07%1 Year Performance-52.51%3.79%34.86%28.46% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny3.092 of 5 stars$15.15+1.0%$27.73+83.0%-52.5%$1.37B$1.09B24.05563Upcoming EarningsTVTYTivity HealthN/A$32.50flatN/A+0.0%$1.62B$481.25M19.01380Analyst ForecastARAAmerican Renal AssociatesN/A$11.52flatN/A+0.0%$397.94M$822.52M-22.154,977SHCSotera Health2.6056 of 5 stars$15.83-0.6%$15.70-0.8%+19.6%$4.48B$1.10B113.073,000Upcoming EarningsCOGlobal Cord BloodN/A$1.25flatN/A+141.1%$363.15M$1.24B1.951,202VMDViemed Healthcare1.7382 of 5 stars$8.88-1.9%N/A+14.0%$344.78M$205.70M37.00630Upcoming EarningsMGRXMangoceuticals1.1821 of 5 stars$2.47+1.6%N/A-98.2%$61.30M$866,792.00-0.383MRAIMarpaiN/A$0.90+11.1%$6.00+566.7%+114.3%$12.37M$37.15M-0.27150Gap UpBRTXBioRestorative Therapies3.7011 of 5 stars$1.53flat$18.00+1,076.5%-21.5%$10.59M$174,100.00-0.757Upcoming EarningsOTRKOntrak1.9515 of 5 stars$1.78-3.3%$45.00+2,428.1%-89.8%$7.51M$12.39M-0.05250Gap UpNIVFNewGenIvf Group1.0415 of 5 stars$0.84+3.7%N/AN/A$3.12M$5.14M0.00N/AGap Down Related Companies and Tools Related Companies Tivity Health Alternatives American Renal Associates Alternatives Sotera Health Alternatives Global Cord Blood Alternatives Viemed Healthcare Alternatives Mangoceuticals Alternatives Marpai Alternatives BioRestorative Therapies Alternatives Ontrak Alternatives NewGenIvf Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PGNY) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGNY Stock Alerts